Building the Largest Kidney-Focused Genomics Registry with Dr. Michael Anger and Jeffrey Carr
Release Date: 05/12/2022
Field Notes
info_outlineField Notes
info_outlineField Notes
info_outlineField Notes
info_outlineField Notes
info_outlineField Notes
info_outlineField Notes
info_outlineField Notes
info_outlineField Notes
April is National Donate Life Month, and during this time, we focus on raising awareness about transplantation and donation honor the people who have saved lives through the gift of donation. Tune in for this special episode today for an update on the latest in transplant medicine. Transplantation is the best method of treatment for many people with end stage kidney disease, when available and accessible. As a company, we prioritize expanding access to kidney transplantation and work to reduce the challenges facing patients as they work towards getting transplanted.
info_outlineField Notes
info_outlineWith the ambitious goal of enrolling more than 100,000 participants within five years, the My Reason campaign aims to build the largest kidney-focused genomics registry of its kind. Dr. Michael Anger, Principal Investigator for the My Reason Genomics and Precision Medicine Initiative, and Jeffrey Carr, Head of Genomics and Precision Medicine, join Field Notes to discuss the significant impact My Reason will have on improving outcomes for kidney disease patients.